Found 2 publications.
Displayed publications from 1 to 2
Expand all publications
Collapse all publications
Show all as text (SweetDB notation)
Show all graphically (SNFG notation)
1. (Article ID: 7537)
Ishibashi Y, Ikeda K, Sakaguchi K, Okino N, Taguchi R, Ito M
Quality control of fungus-specific glucosylceramide in Cryptococcus neoformans by endoglycoceramidase-related protein 1 (EGCrP1)
Journal of Biological Chemistry 287(1) (2012)
368-381
A fungus-specific glucosylceramide (GlcCer), which contains a unique sphingoid base possessing two double bonds and a methyl substitution, is essential for pathogenicity in fungi. Although the biosynthetic pathway of the GlcCer has been well elucidated, little is known about GlcCer catabolism because a GlcCer-degrading enzyme (glucocerebrosidase) has yet to be identified in fungi. We found a homologue of endoglycoceramidase tentatively designated endoglycoceramidase-related protein 1 (EGCrP1) in several fungal genomic databases. The recombinant EGCrP1 hydrolyzed GlcCer but not other glycosphingolipids, whereas endoglycoceramidase hydrolyzed oligosaccharide- linked glycosphingolipids but not GlcCer. Disruption of egcrp1 in Cryptococcus neoformans, a typical pathogenic fungus causing cryptococcosis, resulted in the accumulation of fungus-specific GlcCer and immature GlcCer that possess sphingoid bases without a methyl substitution concomitant with a dysfunction of polysaccharide capsule formation. These results indicated that EGCrP1 participates in the catabolism of GlcCer and especially functions to eliminate immature GlcCer in vivo that are generated as by-products due to the broad specificity of GlcCer synthase. We conclude that EGCrP1, a glucocerebrosidase identified for the first time in fungi, controls the quality of GlcCer by eliminating immature GlcCer incorrectly generated in C. neoformans, leading to accurate processing of fungus-specific GlcCer.
glycosphingolipid, Cryptococcus neoformans, glucosylceramide, EGCase II
NCBI PubMed ID: 22072709Publication DOI: 10.1074/jbc.M111.311340Journal NLM ID: 2985121RPublisher: Baltimore, MD: American Society for Biochemistry and Molecular Biology
Correspondence: Ito M
agr.kyushu-u.ac.jp>
Institutions: Department of Bioscience and Biotechnology, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka, Japan, Department of Metabolome, Graduate School of Medicine, University of Tokyo, Tokyo, Japan, Institute for Advanced Biosciences, Keio University, Yamagata, Japan, Department of Biomedical Sciences, College of Life and Health Sciences, Chubu University, Aichi, Japan, New Energy and Industrial Technology Development Organization (NEDO), MUZA, Kanagawa, Japan, Laboratory for Molecular Membrane Neuroscience, RIKEN Brain Science Institute, Wako, Japan
Methods: DNA sequencing, SDS-PAGE, DNA techniques, TLC, GLC, ESI-MS/MS, MALDI-TOF MS, HPLC, extraction, CC, protein detection, enzymatic assay, derivatization
The publication contains the following compound(s):
- Compound ID: 18694
Structure type: monomer
C43H81O9N
Trivial name: cerebroside C, cerebroside D
Compound class: glycolipid, glycosphingolipid, glycoside, cerebroside, ceramide
- Compound ID: 19097
Structure type: monomer
Compound class: cerebroside, ceramide
- Compound ID: 19098
Structure type: monomer
Compound class: ceramide
- Compound ID: 19099
Structure type: monomer
Compound class: ceramide
Expand this publication
Collapse this publication
2. (Article ID: 8405)
Kudoh A, Okawa Y, Shibata N
Significant structural change in both O- and N-linked carbohydrate moieties of the antigenic galactomannan from Aspergillus fumigatus grown under different culture conditions
Glycobiology 25(1) (2015)
74-87
Invasive aspergillosis is an important cause of morbidity and mortality in immunocompromised patients. Diagnosis of this infection frequently employs detection of the circulating galactomannan in the patient serum using enzyme immunoassay (EIA), a highly sensitive and specific system. Although there are many structural studies of the galactomannan of Aspergillus fumigatus, some inconsistencies are present in these results. In this study, to clarify the relationship between the growth conditions and structure of the galactomannans, we cultured A. fumigatus using two distinct yeast/fungal cultivation media, i.e. the yeast extract-peptone-dextrose (YPD) medium and yeast nitrogen base (YNB) medium. Galactomannans prepared from the resulting culture supernatants were structurally characterized by 1H and 13C nuclear magnetic resonance, methylation analysis, acetolysis and α-mannosidase degradation. These assays revealed that the galactomannan from the YPD cultivation had short β-1,5-linked galactofuranose (Galf) oligosaccharide chains in both the O- and N-linked carbohydrate moieties, while the galactomannan from the YNB cultivation incorporated long Galf oligosaccharide chains. The galactomannans derived from the two culture conditions significantly differed in reactivity based on the EIA diagnostic system. We also demonstrated the presence of a novel Galf-containing branched oligosaccharide in the O-linked moiety
NMR, antigen, oligosaccharide, Galactomannan, Aspergillus
NCBI PubMed ID: 25187160Publication DOI: 10.1093/glycob/cwu091Journal NLM ID: 9104124Publisher: IRL Press at Oxford University Press
Correspondence: nshibata

tohoku-pharm.ac.jp
Institutions: Department of Infection and Host Defense, Tohoku Pharmaceutical University, Sendai, Japan, The Sendai Open Hospital, Sendai, Japan
Methods: 13C NMR, 1H NMR, NMR-2D, GC-MS, enzyme immunoassay, acid hydrolysis, alkaline hydrolysis, enzymatic digestion, acetylation, acetolysis, methylation analysis, reduction, CC, gel permeation chromatography, cell growth, dialysis, enzymatic assay, precipitation, evaporation, DEPT
The publication contains the following compound(s):
- Compound ID: 5977
Structure type: oligomer
Compound class: mannan
Reference(s) to other database(s): GTC:G53402KW, GlycomeDB:
278, CCSD:
32606, CBank-STR:2845
- Compound ID: 17127
Structure type: oligomer
Compound class: O-glycoprotein
Reference(s) to other database(s): GTC:G09141DK, CCSD:
31595, CBank-STR:1620
- Compound ID: 17663
Structure type: oligomer
Reference(s) to other database(s): GTC:G82009ML
- Compound ID: 20996
Structure type: oligomer
Reference(s) to other database(s): GTC:G45335EK
- Compound ID: 20997
Structure type: oligomer
Reference(s) to other database(s): GTC:G07569HG
- Compound ID: 20998
Structure type: oligomer
Reference(s) to other database(s): GTC:G63518EK
- Compound ID: 20999
Structure type: oligomer
Reference(s) to other database(s): GTC:G34492HC
- Compound ID: 21000
Structure type: oligomer
Reference(s) to other database(s): GTC:G96475CL
- Compound ID: 21001
Structure type: oligomer
Reference(s) to other database(s): GTC:G26402MJ
- Compound ID: 21002
Structure type: oligomer
Reference(s) to other database(s): GTC:G58627EA
- Compound ID: 21003
|
a-D-Manp-(1-2)-+
|
b-D-Galf-(1-5)-b-D-Galf-(1-5)-b-D-Galf-(1-6)-a-D-Manp |
Show graphically |
Structure type: oligomer
Reference(s) to other database(s): GTC:G39379OX
- Compound ID: 21004
|
a-D-Manp-(1-2)-+
|
b-D-Galf-(1-5)-b-D-Galf-(1-5)-b-D-Galf-(1-6)-D-Man-ol |
Show graphically |
Structure type: oligomer
Reference(s) to other database(s): GTC:G93998EE
- Compound ID: 21005
|
b-D-Galf-(1-5)-b-D-Galf-(1-5)-b-D-Galf-(1-5)-b-D-Galf-(1-6)-a-D-Manp |
Show graphically |
Structure type: oligomer
Reference(s) to other database(s): GTC:G55175MS
- Compound ID: 21006
|
b-D-Galf-(1-5)-b-D-Galf-(1-5)-b-D-Galf-(1-5)-b-D-Galf-(1-6)-D-Man-ol |
Show graphically |
Structure type: oligomer
Reference(s) to other database(s): GTC:G67086MR
- Compound ID: 21007
|
b-D-Galf-(1-6)-b-D-Galf-(1-5)-b-D-Galf-(1-5)-b-D-Galf-(1-6)-a-D-Manp |
Show graphically |
Structure type: oligomer
Reference(s) to other database(s): GTC:G52461QW
- Compound ID: 21008
|
b-D-Galf-(1-6)-b-D-Galf-(1-5)-b-D-Galf-(1-5)-b-D-Galf-(1-6)-D-Man-ol |
Show graphically |
Structure type: oligomer
Reference(s) to other database(s): GTC:G38893LF
- Compound ID: 21009
|
b-D-Galf-(1-5)-b-D-Galf-(1-5)-b-D-Galf-(1-2)-+
|
-2)-a-D-Manp-(1-2)-a-D-Manp-(1-6)-a-D-Manp-(1-2)-a-D-Manp-(1-2)-a-D-Manp-(1-2)-a-D-Manp-(1-6)-a-D-Manp-(1-2)-a-D-Manp-(1-2)-a-D-Manp-(1-2)-a-D-Manp-(1-6)-a-D-Manp-(1-2)-a-D-Manp-(1- |
Show graphically |
Structure type: structural motif or average structure
Aglycon: (->4) L-Asn (protein)
Compound class: N-polysaccharide
Reference(s) to other database(s): GTC:G66884NV
- Compound ID: 21010
|
?%a-D-Manp-(1-2)-+
|
{{{-b-D-Galf-(1-5)-}}}/n=0-2/-?%b-D-Galf-(1-6)-a-D-Manp-(1--/(->3) L-Thr/L-Ser (protein)/ |
Show graphically |
Structure type: structural motif or average structure
Aglycon: (->3) L-Thr/L-Ser (protein)
- Compound ID: 21011
|
{{{-b-D-Galf-(1-5)-}}}/n=4/-b-D-Galf-(1-6)-{{{-b-D-Galf-(1-5)-}}}/n=3/-b-D-Galf-(1-2)-+
|
{{{-b-D-Galf-(1-5)-}}}/n=4/-b-D-Galf-(1-6)-{{{-b-D-Galf-(1-5)-}}}/n=3/-b-D-Galf-(1-2)-+ |
| |
{{{-b-D-Galf-(1-5)-}}}/n=4/-b-D-Galf-(1-6)-{{{-b-D-Galf-(1-5)-}}}/n=3/-b-D-Galf-(1-2)-+ | |
| | |
-2)-a-D-Manp-(1-2)-a-D-Manp-(1-6)-a-D-Manp-(1-2)-a-D-Manp-(1-2)-a-D-Manp-(1-2)-a-D-Manp-(1-6)-a-D-Manp-(1-2)-a-D-Manp-(1-2)-a-D-Manp-(1-2)-a-D-Manp-(1-6)-a-D-Manp-(1-2)-a-D-Manp-(1- |
Show graphically |
Structure type: structural motif or average structure
Aglycon: (->4) L-Asn (protein)
Compound class: N-polysaccharide
- Compound ID: 21012
|
?%a-D-Manp-(1-2)-+
|
{{{-b-D-Galf-(1-5)-}}}/n=3-4/-?%b-D-Galf-(1-6)-?%b-D-Galf-(1-5)-?%b-D-Galf-(1-5)-?%b-D-Galf-(1-6)-a-D-Manp-(1--/(->3) L-Thr/L-Ser (protein)/ |
Show graphically |
Structure type: structural motif or average structure
Aglycon: (->3) L-Thr/L-Ser (protein)
Reference(s) to other database(s): GTC:G77077SK
Expand this publication
Collapse this publication
Total list of publication IDs on all result pages of the current query:
Total list of corresponding CSDB IDs (permanent record IDs):
Execution: <1 sec